SEC reporting owner

OXFORD BIOSCIENCE PARTNERS IV LP SEC insider disclosures

Explore OXFORD BIOSCIENCE PARTNERS IV LP's reporting-owner identity, issuer relationships, purchases, sales and SEC filing receipts.

As of 2026-10-07T00:29:11.873Z

Reporting owner CIK
0001140484
Issuers
3
Coverage
verified

Issuer relationships

A reporting-owner CIK identifies the filer across issuer relationships and name aliases. A filer may be an individual or an organization; the filing role is the relevant evidence.

Solexa, Inc.0000913275SLXANoNo
Trubion Pharmaceuticals, Inc0001298521TRBNNoNo
Cyberkinetics Neurotechnology Systems, Inc.0001180253CYKNNoNo
Solexa, Inc. ↗Trubion Pharmaceuticals, Inc ↗Cyberkinetics Neurotechnology Systems, Inc. ↗

Recent SEC transactions

Code P identifies a purchase, S a sale and A an award. Awards and open-market purchases describe different events. Use the public availability date when deciding when a researcher could have known about the transaction.

No records are available for this view.

Up to 50 transactions from the recent two-year owner window.

Source evidence and strategy eligibility

The transactions below come from filings; a historical tracker separately simulates following eligible events. Joint filers can report the same transaction, and an owner can have filings at multiple companies. Public availability, amendment lineage and verified coverage determine which events a historical tracker may use.

The current directory marks this owner's filing coverage verified.